Crossmark

Dronabinol has preferential antileukemic activity in acute lymphoblastic and myeloid leukemia with lymphoid differentiation patterns

Crossref DOI link: https://doi.org/10.1186/S12885-015-2029-8

Published: 2016-12

Update policy: https://doi.org/10.1007/SPRINGER_CROSSMARK_POLICY

Authors

Kampa-Schittenhelm, Kerstin Maria

Salitzky, Olaf

Akmut, Figen

Illing, Barbara

Kanz, Lothar

Salih, Helmut Rainer

Schittenhelm, Marcus Matthias
License Information

unspecified valid from 2016-01-16